AGM Information • Mar 22, 2021
AGM Information
Open in ViewerOpens in native device viewer

Notice of Annual General Meeting 2021
Ibstock plc 54 Hatton Garden London EC1N 8HN.
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspect of the proposals referred to in the document or as to the action you should take, you should seek your own advice from a stockbroker, solicitor, accountant or other independent professional adviser. If you have sold or otherwise transferred all of your Ibstock Plc shares, please pass this document, together with the accompanying documents, to the purchaser or transferee, or to the person who arranged the sale or transfer, so that they can pass them to the person who now holds the shares.
You will not have received a hard copy proxy form for the 2021 AGM in the post. You can instead submit your proxy vote electronically by accessing the shareholder portal at www.signalshares.com, logging in and selecting the 'Vote Online Now' link. You will require your username and password in order to log in and vote. If you have forgotten your username or password, you can request a reminder via the shareholder portal. If you have not previously registered to use the portal you will require your investor code ("IVC") which can be found on your share certificate or dividend notification. Proxy votes should be submitted as early as possible and in any event, no later than 11.00 a.m. on 20 April 2021. You may request a hard copy proxy form directly from the Registrars, Link Group by emailing [email protected] or by post at Link Group, 10th Floor, Central Square, 29 Wellington Square, Leeds LS1 4DL. If you hold shares in CREST you can use the CREST electronic proxy appointment service. Further details on how to do this are set out in the notes on page 7.
(incorporated in England and Wales under number 09760850)
Registered Office: Leicester Road, Ibstock, Leicestershire LE67 6HS, United Kingdom
To the shareholders of Ibstock plc (the "Company")
22 March 2021
Dear Shareholder,
The Annual General Meeting ("AGM" or "Meeting") of the Company will be held at 11:00 a.m. on Thursday 22 April 2021 at 54 Hatton Garden, London EC1N 8HN
Our preference had been to welcome shareholders in person to our AGM this year, particularly given the constraints we faced in 2020 due to COVID-19. However, at the time of posting, we remain in a national lockdown and, as a result, are therefore proposing to hold the meeting with the minimum attendance necessary to form a quorum. Shareholders will not be permitted to attend the AGM in person but can be represented by the Chairman of the meeting acting as their proxy.
Given the constantly evolving nature of the situation, should circumstances change before the date of the meeting, we want to ensure that we are able to adapt arrangements and welcome shareholders to the AGM, within existing safety constraints and in accordance with government guidelines. Should we consider that it has become possible to do so, we will open the meeting to attendance from all shareholders and provide notification of this change through a Regulatory Information Service (RIS) announcement as early as possible before the date of the meeting. Please refer to the Shareholder information section of our website at www.ibstockplc.co.uk for any updates to this position.
To increase the level of transparency with our shareholders, and encourage engagement, the Company will provide access for individuals wishing to view a webcast of the AGM online and further information regarding this service will be published on our website. In addition, any shareholder who wishes to ask a question can do so in advance of the meeting by emailing [email protected] prior to the start of the AGM. We endeavour to answer as many questions as possible, prior to, and during the AGM, and will respond by email if we are unable to answer your question during, or prior to, the meeting.
Given the continued uncertainty around whether shareholders will be able to attend the AGM, we recommend that all shareholders submit a proxy vote in advance of the meeting. Details on how to do so by post, online or through CREST are set out below and in the general notes on page 7. Given the current restrictions on attendance, shareholders are urged to appoint the Chairman of the meeting as their proxy to ensure their vote will be counted (rather than a named person who will not be permitted to attend the meeting).
The formal Notice convening the AGM and which sets out the business to be considered can be found on pages 3 and 4 of this document along with explanatory notes to the resolutions on pages 5 and 6. General notes relating to the AGM are on page 7. Voting on all resolutions will be by way of a poll.
If you have elected to receive hard copy information from the Company, the Annual Report and Accounts 2020 (the "Annual Report") is enclosed with this document. Shareholders who have not made such an election can view or download the Annual Report from our website. Ibstock is committed to reducing paper and improving efficiency wherever possible in its communications with shareholders. As part of this we are no longer sending paper proxy cards to shareholders unless specifically asked to do so. Advice on how to request a paper proxy is set out in note 4 on page 7 of this Notice.
Your vote is important to us and we encourage you to submit your proxy vote in one of the following ways:
Please note that the deadline for the receipt by our Registrars of all proxy appointments is 11:00 a.m. on Tuesday 20 April 2021 (48 hours before the start of the meeting). In view of current government restrictions on public gatherings, we urge you to appoint the Chairman of the meeting as your proxy, to ensure your vote will be counted.
The results of the AGM will be announced through an RIS announcement and on the Company website, as soon as practicable after the AGM.
Your Board considers that all resolutions set out in this notice of AGM are in the best interests of the Company and its shareholders as a whole. Accordingly, the Directors recommend shareholders to vote in favour of these resolutions, as they intend to do in respect of their own beneficial shareholdings.
Yours faithfully,
Chairman
NOTICE IS HEREBY GIVEN that the Annual General Meeting ("AGM") of Ibstock plc will be held at 11:00 a.m. on Thursday 22 April 2021 at 54 Hatton Garden, London EC1N 8HN to consider and, if thought fit, pass the following resolutions. Resolutions 1 to 15 will be proposed as ordinary resolutions of the Company, and Resolutions 16 to 19 will be proposed as special resolutions of the Company.
For the purpose of this resolution the terms "political donations", "political parties", "independent election candidates", "political organisations" and "political expenditure" have the meanings set out in sections 363 to 365 of the Companies Act 2006.
continued
That:
(a) in accordance with Article 8 of the Company's Articles of Association, the Directors be given power to allot equity securities for cash;
in either case as if section 561 of that Act did not apply to the allotment or sale, but this power shall be:
By order of the Board,
Company Secretary
Registered office: Leicester Road Ibstock, Leicestershire LE67 6HS United Kingdom
Registered number 09760850
22 March 2021
The notes on the following pages give an explanation of the proposed resolutions.
Resolutions 1 to 15 are proposed as ordinary resolutions. This means that for each of those resolutions to be passed, more than half of the votes cast must be in favour of the resolution. Resolutions 16 to 19 are proposed as special resolutions. This means that for each of those resolutions to be passed, at least three-quarters of the votes cast must be in favour of the resolution.
The Directors must present the Company's annual accounts and reports to the AGM.
Shareholders are asked to approve the Directors' Remuneration Report that appears on pages 85 to 101 of the Annual Report and Accounts 2020 (excluding the part containing the Directors' Remuneration Policy). This vote is advisory, and the Directors' entitlement to remuneration is not conditional on it.
The Board proposes a final dividend of 1.6p per ordinary share. If approved, the dividend will be paid on 14 May 2021 to all shareholders who were on the Register of Members at close of business on 16 April 2021.
The Company's Articles of Association require all Directors to retire at each AGM and those wishing to serve again to submit themselves for election or re-election. Accordingly, all the Directors are retiring from office and submitting themselves for re-election by the shareholders at the 2021 AGM.
A summary of the skills and experience of each Director, which, in the Board's view illustrates why each Director's contribution is, and continues to be, important to the Company's long-term sustainable success, can be found in the Appendix to this document.
The Chairman has confirmed that, following formal performance evaluation, the performance of all Directors continues to be effective and to demonstrate commitment to the role.
Following the recommendation of the Audit Committee, the Board is proposing the re-appointment of Deloitte LLP as the Company's auditor.
Resolution 12 authorises the Audit Committee to determine the auditor's remuneration.
The Company has two share plans in place for senior employees – a long-term incentive plan for Executive Directors and senior management and a share option plan for the wider management team below senior management level.
Following consideration of the current remuneration policy and best practice, the Remuneration Committee of the Board ("Committee") has decided to implement the SMSP for the wider management pool to replace the share option plan. The current long-term incentive plan for Executive Directors and senior management will continue for those individuals.
The background to this decision is the Committee's recognition that the share option plan may not be fostering the strong performance-led culture that the Company wants to achieve. Under the SMSP, the Board will be able to select employees to be granted performance-linked awards to address this issue and the value of awards will be lower as there will be no share price hurdle as there is with share options.
A summary of the terms of the SMSP is set out at Appendix 2.
Part 14 of the Companies Act 2006, amongst other things, prohibits the Company and its subsidiaries from making EU political donations or from incurring political expenditure in respect of a political party or other political organisation or an independent election candidate unless authorised by the Company's shareholders. Aggregate donations made by the Group of £5,000 or less in any 12-month period will not be caught.
Neither the Company nor any of its subsidiaries has any intention of making any political donations or to incur any political expenditure. However, the Companies Act 2006 defines "political party", "political organisation", "political donation" and "political expenditure" widely. For example, bodies, such as those concerned with policy review and law reform or with the representation of the business community or sections of it, which the Company and/or its subsidiaries may see benefit in supporting, may be caught.
Accordingly, the Company wishes to ensure that neither it nor its subsidiaries inadvertently commits any breaches of the Companies Act 2006 through the undertaking of routine activities, which would not normally be considered to result in the making of political donations and political expenditure being incurred.
As permitted under the Companies Act 2006, the resolution covers the Company and extends to all companies which are subsidiaries of the Company at any time the authority is in place. The proposed authority will expire at the next AGM of the Company or, if earlier, at close of business on 1 July 2022.
At the 2020 AGM, the Directors were authorised, under section 551 of the Companies Act 2006, to allot ordinary shares without the prior consent of shareholders for a period expiring at the conclusion of the AGM to be held in 2020 or, if earlier, the close of business on 1 July 2021. It is proposed to renew this authority.
Paragraph (a)(i) of Resolution 15 will allow the Directors to allot ordinary shares up to a maximum nominal amount of £1,365,062 representing approximately one-third of the Company's existing issued share capital and calculated as at 16 March 2021 (being the latest practicable date prior to publication of this document). In accordance with institutional guidelines issued by the Investment Association, paragraph (a)(ii) of Resolution 15 will allow Directors to allot, including the ordinary shares referred to in paragraph (a)(i) of Resolution 15, further of the Company's ordinary shares in connection with a pre-emptive offer by way of a rights issue to ordinary shareholders up to a maximum nominal amount of £2,730,125, representing approximately two-thirds of the Company's existing issued share capital and calculated as at 16 March 2021 (being the latest practicable date prior to publication of this document).
The Directors have no present intention of exercising this authority but believe that it is in the best interests of the Company to have the authority available so that the Board has the flexibility to issue shares at short notice and without the need for a general meeting should the Board determine that it is appropriate to do so. However, if they do exercise the authority, the Directors intend to follow best practice as regards its use, as recommended by the Investment Association.
As at 16 March 2021 (being the latest practicable date prior to publication of this document), the Company did not hold any shares in treasury.
Resolution 15 will be proposed as an ordinary resolution to renew this authority until the conclusion of the next AGM or, if earlier, the close of business on 1 July 2022.
Also at the 2020 AGM, a special resolution was passed, under sections 570 to 573 of the Companies Act 2006, empowering the Directors to allot equity securities for cash without first being required to offer such shares to existing shareholders. It is proposed that this authority also be renewed in line with institutional guidelines. If approved, the resolution will authorise the Directors, in accordance with the Articles of Association, to issue shares in connection with a rights issue or other pre-emptive offer and otherwise to issue shares for cash up to a maximum nominal amount of £204,779 which includes the sale on a non pre-emptive basis of any shares the Company holds in treasury for cash. The £204,779 maximum nominal amount of equity securities to which this authority relates represents approximately 5% of the issued share capital of the Company as at 16 March 2021 (being the latest practicable date prior to publication of this document).
continued
The Directors do not intend to issue more than 7.5% of the issued share capital of the Company for cash on a non pre-emptive basis in any rolling three-year period (other than in connection with an acquisition or specified capital investment as described in the Pre-emption Group's Statement of Principles) without prior consultation with shareholders.
Resolution 16 will be proposed as a special resolution to renew this authority until the conclusion of the next AGM or, if earlier, the close of business on 1 July 2022.
Resolution 17 requests further shareholder approval, by way of a separate special resolution in line with the best practice guidance issued by the Pre-Emption Group, for the Directors to allot equity securities or sell treasury shares for cash without first being required to offer such securities to existing shareholders.
The proposed resolution reflects the Pre-emption Group's 2015 Statement of Principles for the disapplication of pre-emption rights (the "Statement of Principles") and will expire on 1 July 2022 or at the conclusion of the AGM in 2022, whichever is the earlier.
The authority granted by this resolution, if passed:
The authority granted by this resolution would be in addition to the general authority to disapply pre-emption rights under Resolution 16. The maximum nominal value of equity securities which could be allotted if both authorities were used would be £409,559, which represents approximately 10% of the issued share capital of the Company as at 16 March 2021 (being the latest practicable date prior to publication of this circular).
A special resolution is proposed, in line with market practice, to authorise the purchase of the Company's own shares in the market. The power given by the resolution will only be exercised if the Directors are satisfied that any purchase will increase the earnings per share of the ordinary share capital in issue after the purchase and, accordingly, that the purchase is in the interests of shareholders. The Directors will also give careful consideration to gearing levels of the Company and its general financial position. The purchase price would be paid out of distributable profits.
The Companies Act 2006 permits certain listed companies to hold shares in treasury, as an alternative to cancelling them, following a purchase of own shares by the company. Shares held in treasury may subsequently be cancelled, sold for cash or used to satisfy share options and share awards under the company's employees' share schemes. Once held in treasury, the company is not entitled to exercise any rights, including the right to attend and vote at meetings in respect of the shares. Further, no dividend or other distribution of the company's assets may be made to the company in respect of the treasury shares.
If the Directors exercise the authority conferred by this resolution, they may consider holding those shares in treasury, rather than cancelling them. The Directors believe that holding shares in treasury would provide the Company with greater flexibility in the management of its share capital. The Directors will also consider using the treasury shares to satisfy share options/awards under the Company's employees' share schemes.
The maximum number of shares which may be purchased under the proposed authority will be 40,955,979 shares representing approximately 10% of the issued ordinary share capital of the Company as at 16 March 2021. The price paid for shares will not be less than the nominal value (of 1p per share) nor more than the higher of:
The total number of options to subscribe for ordinary shares that were outstanding at 16 March 2021 (being the latest practicable date prior to publication of this circular) was 3,075,898. The proportion of issued share capital that they represented at that time was 0.75% and the proportion of issued share capital that they will represent if the full authority to purchase shares (existing and being sought) is used is 0.83%.
This resolution will be proposed as a special resolution. The authority will expire on 1 July 2022 or, if earlier, at the conclusion of the next year's AGM.
The notice period required by the Companies Act 2006 for General Meetings of the Company is 21 clear days unless shareholders approve a shorter notice period, which cannot however be less than 14 clear days. (AGMs must always be held on at least 21 clear days' notice.) This resolution, if passed, authorises the calling of General Meetings other than an AGM on not less than 14 clear days' notice, and will be effective until the Company's next AGM, when it is intended that a similar resolution will be proposed. In order to be able to call a General Meeting on less than 21 clear days' notice, the Company must make a means of electronic voting available to all shareholders for that meeting. The flexibility offered by this resolution will be used where, taking into account the circumstances, the Directors consider this appropriate in relation to the business to be considered at the meeting and in the interests of the Company and shareholders as a whole.
BA (Hons), ACA, FCT Chairman
22 September 2015 (Chairman since 24 May 2018)
Chair of the Nomination Committee Remuneration Committee
• Chairman of Shaftesbury PLC (appointed September 2016)
Independent Non-Executive Director
1 June 2018
Remuneration Committee Audit Committee Nomination Committee
Date appointed to the Board: 3 February 2016
Chair of the Remuneration Committee Audit Committee Nomination Committee
BSc (Hons), MBA Independent Non-Executive Director
1 September 2018
Remuneration Committee Audit Committee Nomination Committee
• None
BA (Hons), FCIPD Chief Executive Officer
2 January 2018 (CEO since 4 April 2018)
Committee memberships: None
• None
BSc ACA
Chief Financial Officer
1 August 2019 (CFO since 31 August 2019)
Committee memberships: None
• None
1 January 2017
Chair of the Audit Committee Remuneration Committee Nomination Committee
Awards may be granted to employees of the Company and its subsidiaries at the discretion of the Board but may not be granted to Directors of the Company.
Participants are granted a right to receive ordinary shares and they do not pay for their award. The award can take the form of (i) a conditional right to acquire ordinary shares in the future at no cost to the participant or (ii) an option to acquire ordinary shares (with or without an option price).
Awards may normally only be granted in the six weeks beginning with the date on which the SMSP is approved by the Company's shareholders and then in the six weeks beginning on the dealing day after the Company announces its results for any period. Awards may be granted outside these periods in exceptional circumstances.
Subject to shareholder approval of the SMSP, it is anticipated that the first awards will be granted in April/May 2021. No awards may be granted more than 10 years from the date of approval of the SMSP by the Company's shareholders.
Awards granted under the SMSP are personal to the participant and, except on the death of the participant or if they are declared bankrupt (unless the Board determines otherwise), may not be transferred. Awards granted under the SMSP are not pensionable.
The Board will determine the value of awards to be granted to a participant in each financial year. The rules permit annual awards up to a maximum of 100% of base salary per participant but, in practice, awards are expected to be towards the bottom end of the range.
The number of ordinary shares which may be issued for awards granted in any period of 10 years under:
The Board currently intends that the first awards will be subject to the performance condition set out below but may set a different performance condition for subsequent awards.
The performance condition relates to the Company's adjusted EBITDA across two financial years, 2021 and 2022, with 50% of the award vesting for meeting threshold performance and 100% of the award vesting for meeting target performance.
In normal circumstances, an award will vest on the later of the second anniversary of grant and the date that the Board determines whether the performance condition and any other conditions imposed have been satisfied.
The Board may decide that participants should receive an additional benefit equal in value to any dividends that they would have received during the vesting period, if they had been the holders of the vested ordinary shares. The benefit can be provided in cash or in ordinary shares. Alternatively, the Board may grant an award on terms that the number of ordinary shares under award shall increase by assuming that dividends that would have been paid on those ordinary shares during the vesting period would have been used to buy further ordinary shares.
Where an award has vested (or, in the case of an option, has been exercised), the Board may elect, instead of delivering ordinary shares, to pay cash to the participant. The amount to be paid (subject to deduction of tax or similar liabilities) shall be equal to the market value of the ordinary shares under award (determined by reference to the closing middle market quotation of ordinary shares on the London Stock Exchange Daily Official List on the day of vesting (or exercise, in the case of options).
The SMSP also has flexibility to allow cash-settled awards to be granted from the outset, if the Board considers this appropriate in a particular case.
There are different vesting terms where a participant leaves:
Awards will vest early on a change of control of the Company to the extent any performance condition has been met at that time and, unless the Board decides otherwise, will be pro-rated for time. Internal reorganisation does not automatically trigger the early vesting of awards and certain other events may lead to a rollover of existing awards.
If any other corporate events occur such as a demerger, delisting or special dividend which, in the opinion of the Board, may affect the current or future value of ordinary shares, the Board may allow awards to vest early (subject to performance and, unless decided otherwise, time pro rating).
On any variation in the share capital of the Company, the Board may make adjustments as it considers appropriate to the number of ordinary shares under award and, where appropriate, the exercise price of an option.
The Board may, prior to, or within two years of, the vesting of an award, decide to reduce the number of ordinary shares or, where relevant, the cash amount to which an award relates (malus) or require the participant to make a repayment in respect of an award (clawback), where it considers appropriate (including, but not limited to, material misstatement of results of the Company, inaccurate or misleading information leading to incorrect grant or vesting of an award, participant misconduct, circumstances which have or could have caused serious harm to the reputation of the Company).
The Board can amend the SMSP in any way. However, shareholder approval will be required to amend provisions to the advantage of participants which relate to eligibility, individual and plan limits, the basis for determining a participant's entitlement to, and the terms of, the ordinary shares or cash under award, the adjustment of awards on any variation in the Company's share capital and the amendment powers.
Minor amendments can however be made without shareholder approval to benefit the administration of the SMSP, to take account of a change in legislation or to obtain or maintain favourable tax, exchange control or regulatory treatment.

Ibstock plc Leicester Road Ibstock, Leicestershire LE67 6HS T: +44 (0)1530 261 999 www.ibstockplc.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.